Reduction-Responsive Stearyl Alcohol-Cabazitaxel Prodrug Nanoassemblies for Cancer Chemotherapy.

Liu, Yuting; Wang, Xinhui; Wang, Zhe; Liao, Rui; Qiu, Qian; Wang, Yuequan; Luo, Cong

Liu, Yuting; Wang, Xinhui; Wang, Zhe; Liao, Rui; Qiu, Qian; Wang, Yuequan; Luo, Cong.

Afiliación

Liu Y; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.
Wang X; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.
Wang Z; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.
Liao R; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.
Qiu Q; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.
Wang Y; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.
Luo C; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.

Pharmaceutics ; 15(1)2023 Jan 12.

Article en En | MEDLINE | ID: mdl-36678891

Palabras clave

cabazitaxel; cancer therapy; disulfide bond; prodrug nanoassemblies; reduction-responsive

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Pharmaceutics Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google